Interesting data, however interpretation may be limited by small number of reported cases and confounding selection bias.
Women with atypical hemolytic uremic syndrome treated with eculizumab have similar pregnancy outcomes to women who were not treated with eculizumab, according to a review of post-marketing safety data presented at #ISTH2019 ashclinicalnews.org/on-locat…
Its very rewarding to share with students our experience in this informal setting. Thank you @anjleemd
